Tirzepatide-Induced Injection Site Reaction

被引:4
|
作者
Mizumoto, Junki [1 ]
机构
[1] Univ Tokyo, Int Res Ctr Med Educ, Grad Sch Med, Dept Med Educ Studies, Tokyo, Japan
关键词
tirzepatide; rash; glucagon-like peptide-1 receptor agonist; diabetes mellitus; adverse drug reaction;
D O I
10.7759/cureus.45181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A male in his 70s developed a rash on his lower abdomen after changing his subcutaneous injection drug from dulaglutide to tirzepatide. The rash diminished after stopping tirzepatide injection. This case illustrated that tirzepatide can potentially lead to an injection site rash, despite another glucagon-like peptide-1 (GLP-1) receptor agonist (RA) being used without adverse reactions. Injection site reactions are one of the potential adverse events associated with GLP-1 RA use. To the best of our knowledge, this is the first reported case of tirzepatide-induced injection site reaction.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Tirzepatide-Induced Biphasic Anaphylactic Reaction: A Case Report
    He, Zhexiang
    Tabe, Agborya N.
    Rana, Sohaib
    King, Kristy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [2] A Rare Case of Tirzepatide-Induced Hepatotoxicity
    Sohal, Aalam
    Casanova, Luis
    Kowdley, Kris V.
    ACG CASE REPORTS JOURNAL, 2024, 11 (10)
  • [3] Tirzepatide-induced starvation ketoacidosis: a case report
    Mercer, Julianne
    Lipscomb, Jeremy
    Lipscomb, Justina
    Gao, Han
    King, Kevin
    CLINICAL TOXICOLOGY, 2023, 61 : 14 - 15
  • [4] A Rare Case of Tirzepatide-Induced Liver Injury
    Berihun, Achashman
    Sohal, Aalam
    Kowdley, Kris
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2282 - S2283
  • [5] Weight Loss at a Price: Tirzepatide-induced Pneumatosis Intestinalis
    Kolli, Sindhura
    Gurala, Dhineshreddy
    Chalhoub, Jean
    Andrawes, Sherif
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2484 - S2484
  • [6] Tirzepatide-Induced Rapid Weight Loss-Related Thyrotoxicosis
    Karakus, Kagan E.
    Shah, Viral N.
    Akturk, Halis K.
    JAMA INTERNAL MEDICINE, 2024, 184 (10) : 1246 - 1247
  • [7] Tirzepatide-Induced Gastrointestinal Manifestations: A Systematic Review and Meta-Analysis
    Karrar, Hani Raka
    Nouh, Mahmoud Ismail
    Nouh, Yousef Ismail
    Nouh, Mawadah Ismaeel
    Alhindi, Adel S. Khan
    Hemeq, Yousef Hassan
    Aljameeli, Abdullah Mohammed
    Aljuaid, Jameel Abdullah
    Alzahrani, Saleh Jabbar
    Alsatami, Abdullah Abdulrahman
    Alkredees, Mona Ali
    Almuqati, Abdulrahman Olayan
    Abanmi, Sobhia N.
    Alshehri, Amal Mueidh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [8] Tirzepatide-induced weight loss in type 2 diabetes is independent of nausea, vomiting, or diarrhoea
    Patel, H.
    Khunti, K.
    Rodbard, H. W.
    Bajaj, H. S.
    Bray, R.
    Kindracki, Z.
    Rodriguez, A.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S290 - S291
  • [9] Liraglutide-Induced Injection Site Reaction
    Neel, Nada Fouda
    Ghobara, Yasser
    Turkmani, Mohammed
    JOURNAL OF DERMATOLOGY DERMATOLOGIC SURGERY-JDDS, 2019, 23 (02): : 97 - 98
  • [10] Enoxaparin-induced injection site reaction - New reaction?
    Benjamin, L
    Connelly, EA
    Romanelli, P
    Schachner, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB99 - AB99